Tech-enabled drug discovery company Valo Health announced today plans to go public through a $2.8 billion SPAC deal with Khosla Ventures Acquisition Co., a special purpose acquisition company from Khosla Ventures.
The deal, which is expected to close in the third quarter of this year, will deliver approximately $168.5 million in proceeds in private investment in public equity (PIPE) funding from...
Health insurtech company Oscar Health scored a whopping $225 million in Series C funding from Google’s parent company Alphabet, General Catalyst, Khosla Ventures, Lakestar, Thrive Capital and Baillie Gifford.
This comes roughly two years after the company announced a $165 million funding round led by Brian Singerman and Founders Fund.
WHAT THEY DO
The company offers direct-to-consumer health...
